Curcumin
姜黄素
Report date: 2026/04/22 20:01:10
NME
Base Information
Drug NameCurcumin
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[68]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[17]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A
Develop Information
Active CompaniesUniversity of Texas Southwestern Medical CenterCairo UniversityStanford University +[18]
Inactive CompaniesInstituto Nacional De Cardiologia Ignacio ChavezUniversity Of California San FranciscoInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement +[30]
Active Indications +[23]
Inactive Indications +[45]